EMA backs Merck’s Welireg, Bayer’s ATTR med and Gilead’s liver drug from $4.3B deal

13th December 2024 Uncategorised 0

EMA backs Merck’s Welireg, Bayer’s ATTR med and Gilead’s liver drug from $4.3B deal
aliu
Fri, 12/13/2024 – 10:41

More: EMA backs Merck’s Welireg, Bayer’s ATTR med and Gilead’s liver drug from .3B deal
Source: fierce